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OBJECTIVES To determine the clinical features of a novel heart syndrome with transient left ventricular
(LV) apical ballooning, but without coronary artery stenosis, that mimics acute myocardial
infarction, we performed a multicenter retrospective enrollment study.
BACKGROUND Only several case presentations have been reported with regard to this syndrome.
METHODS We analyzed 88 patients (12 men and 76 women), aged 67 6 13 years, who fulfilled the
following criteria: 1) transient LV apical ballooning, 2) no significant angiographic stenosis,
and 3) no known cardiomyopathies.
RESULTS Thirty-eight (43%) patients had preceding aggravation of underlying disorders (cerebrovas-
cular accident [n 5 3], epilepsy [n 5 3], exacerbated bronchial asthma [n 5 3], acute
abdomen [n 5 7]) and noncardiac surgery or medical procedure (n 5 11) at the onset.
Twenty-four (27%) patients had emotional and physical problems (sudden accident [n 5 2],
death/funeral of a family member [n 5 7], inexperience with exercise [n 5 6], quarreling or
excessive alcohol consumption [n 5 5] and vigorous excitation [n 5 4]). Chest symptoms
(67%), electrocardiographic changes (ST elevation [90%], Q-wave formation [27%] and
T-wave inversion [97%]) and elevated creatine kinase (56%) were found. After treatment of
pulmonary edema (22%), cardiogenic shock (15%) and ventricular tachycardia/fibrillation
(9%), 85 patients had class I New York Heart Association function on discharge. The LV
ejection fraction improved from 41 6 11% to 64 6 10%. Transient intraventricular pressure
gradient and provocative vasospasm were documented in 13/72 (18%) and 10/48 (21%) of the
patients, respectively. During follow-up for 13 6 14 months, two patients showed recurrence,
and one died suddenly.
CONCLUSIONS A novel cardiomyopathy with transient apical ballooning was reported. Emotional or physical
stress might play a key role in this cardiomyopathy, but the precise etiologic basis still remains
unclear. (J Am Coll Cardiol 2001;38:11–8) © 2001 by the American College of Cardiology
A heart syndrome exhibiting acute onset, transient (revers-
ible) left ventricular (LV) apical wall motion abnormalities
with chest symptoms, electrocardiographic (ECG) changes
(ST elevation or depression, abnormal Q-wave) and mini-
mal myocardial enzymatic release mimicking acute myocar-
dial infarction (AMI) in patients without angiographic
stenosis on coronary angiogram (CAG) has been reported.
It was first described by Satoh et al. (1) and Dote et al. (2)
and was named “Takotsubo”-shaped cardiomyopathy due to
its unique “short neck round-flask”-like LV apical balloon-
ing resembling the tako-tsubo (Japanese for octopus pot or
trap) of Japan. Several cases have been reported in Japan
(3–6). A similar type of apical wall motion abnormality has
also been reported in myocardial injury in several systemic
disorders, including multivessel vasospasm, cerebrovascular
accidents, gastrointestinal bleeding and pheochromocytoma
(7–13). However, previous case reports from single centers
have only presented some of the clinical characteristics, and
no clinical studies using the same diagnostic criteria have
been performed. Therefore, the precise clinical features and
the etiologic basis of this syndrome remain unclear.
To determine the clinical characteristics of transient
apical ballooning, the members of Angina Pectoris-
Myocardial Infarction (AP-MI) investigations in Japan have
retrospectively registered and analyzed patients.
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SUBJECTS AND METHODS
Registration criteria. From December 1991 to June 2000,
a total of 125 patients with transient LV apical wall motion
abnormalities without stenosis on CAG were retrospectively
enrolled from cardiovascular institutes of AP-MI investiga-
tions in Japan (see Appendix). In this study, data from 88
patients were selected for analysis based on the following
criteria: 1) patients with suspected AMI based on chest
symptoms or ECG changes (ST-T changes, abnormal
Q-wave formation); 2) transient LV ballooning confirmed
by left ventriculography (LVG) or echocardiography; and 3)
CAG-confirmed normal epicardial artery (luminal narrow-
ing of ,50% in all three coronary arteries) within 48 h of
the onset.
In these selected patients, LV apical ballooning was
confirmed by LVG in 77 patients (88%) in the acute phase
(8 6 9 h after onset; range, 1 to 48 h) and by echocardi-
ography in all the subjects immediately after the onset.
Patients with idiopathic cardiomyopathy, febrile disorders,
pheochromocytoma or prior history of myocardial infarction
and those receiving coronary revascularization therapy were
excluded from this study. Thirty-seven of the 125 patients
were excluded from this study due to a lack of coronary
angiographic evaluation in the acute period (n 5 35) or due
to an underlying disorder (pheochromocytoma, n 5 2). For
analyses of 12-lead ECG findings and quantitative LV wall
motion, patients with atrial fibrillation, intraventricular
conduction abnormalities and frequent premature ventricu-
lar contractions were also excluded.
Methods. Clinical characteristics (age, gender, onset, cor-
onary risk factors) and the condition that preceded onset as
a possible triggering factor were analyzed. Major coronary
risk factors were determined by the Sixth Report of the Joint
National Committee (1997) in hypertension and by the
American Diabetes Association (1998) in diabetes. Hyper-
lipidemia was defined as hypercholesterolemia of $220 mg/dl
or hypertriglycemia of $150 mg/dl. Cardiac enzyme release
(creatine kinase [CK] release measured every 3 or 4 h [n 5
88] and troponin T release measured once a day [n 5 43])
for determining peak values and 12-lead ECG findings (ST
shifts, T-wave changes and Q-wave formation in all leads)
were examined in each registered center.
In the acute period, LV end-diastolic pressure and
intraventricular pressure gradient, in which .30 mm Hg is
defined as significant, were measured in 72 patients. Left
ventricular wall motion was analyzed using contrast LVG.
In the subacute period (24 6 11 days; range: 13 to 53 days),
vasospasm was assessed in 48 (55%) of the patients by a
previously validated method using intracoronary acetylcho-
line administration (14). The functional change in LV wall
motion was studied by LVG in 56 (64%) of the patients,
and intraventricular pressure gradient was also examined.
Complications (arrhythmias, pulmonary edema and car-
diogenic shock) and the use of intravenous catecholamine
and assist devices (intra-aortic balloon pumping, percutane-
ous cardiopulmonary support system) were examined by
review of medical records. In-hospital death and late
follow-up of recurrences were also investigated by direct
interviews with patients and by reviewing medical records.
Statistical analysis. All of the data are expressed as
mean 6 1 SD. The differences between cardiac functions on
LVG in the acute and subacute periods were compared using
paired Student t tests. The differences between incidences in
two groups were analyzed by the chi-square test. A p
value , 0.05 was considered to be statistically significant.
RESULTS
Representative patients. CASE 1. A 72-year-old woman
was admitted to Sapporo Medical University (Sapporo,
Japan) on September 17, 1997 due to exacerbation of
bronchial asthma and was transferred from another hospital.
Ten days later, she felt chest pain at rest. A 12-lead ECG
showed ST elevation in I, aVL and V1 to V5 (max 14.5 mm
in V3), reciprocating ST depression II, III, aVF and V6 and
abnormal Q-wave in leads V1 to V4 (Fig. 1). One hour later,
LVG revealed LV apical ballooning (Fig. 1), but no
significant stenosis on CAG was confirmed. Intracardiac
pressure recording (Fig. 2) showed intraventricular pressure
gradient estimated at 75 mm Hg. Maximally released CK
was 242 IU/l. After 14 days, the ECG had no ST elevation
or abnormal Q-wave but showed a typical coronary T-wave
in leads aVL and V1 to V4. The LVG demonstrated
remarkable functional recovery with an ejection fraction of
72% (Fig. 1), and the intraventricular pressure gradient
disappeared (Fig. 2).
CASE 2. A 75-year-old woman was admitted to National
Cardiovascular Center (Suita, Osaka, Japan) after sudden
onset of chest pain. The ECG showed ST elevation in leads
II, III, aVF and V3 to V6 (max 12.2 mm in V5). Initial
LVG revealed typical apical ballooning (Fig. 3). The CAG
did not show any significant luminal narrowing. At 28 days
after admission, the ECG improved and only exhibited a
negative T-wave. Follow-up CAG was performed, and it
was found that apical ballooning had completely disap-
peared. Maximal CK release was 206 IU/l. Intracoronary
acetylcholine did not reveal any vasospasm. Nuclear cardio-
graphic evaluations showed marked perfusion-metabolic
mismatches, mainly at the LV apex (Fig. 4). After five
months, all of the nuclear images became normal, and
positron emission computed tomogram by N-13 ammonia
Abbreviation and Acronyms
AMI 5 acute myocardial infarction
AP-MI 5 Angina Pectoris-Myocardial Infarction
investigations
CAG 5 coronary angiogram or coronary angiographic
CK 5 creatine kinase
ECG 5 electrocardiogram or electrocardiographic
LV 5 left ventricle or left ventricular
LVG 5 left ventriculography or left ventriculographic
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showed depressed flow-reserve. However, five months later
the positron emission computed tomogram was normal.
Possible triggering factors at the onset of transient LV
apical ballooning. Various psychological and physical con-
ditions have been documented. Eighteen patients had emo-
tional problems at the onset: sudden accidents (n 5 2: a
house fire in which the husband suffered severe burns,
witnessing a grandson’s traffic accident) and death/funeral
(n 5 7: sudden death of a husband, attending the funeral of
a relative, anxiety over a congenital disorder in a family
member), quarreling or excessive alcohol consumption (n 5
5) and vigorous excitation (n 5 4: while watching TV or
Figure 1. Representative electrocardiographic changes and left ventriculogram of transient left ventricular (LV) apical ballooning (Case 1). (Left) 12-lead
electrocardiogram during chest pain (B) demonstrated ST elevation in leads I, aVL, V1 to V5 and reciprocating ST depression in leads II, III and aVF
compared with control (A). Fourteen days after onset (C), a coronary T-wave was confirmed. (Right) Left ventriculogram demonstrated LV apical
ballooning. After 15 days, almost all of the contracted LV configuration recovered to normal.
Figure 2. Changes in intracardiac pressure recording (Case 1). Intraventricular pressure recording immediately after onset revealed a significant
intraventricular pressure gradient (PG), estimated to be 75 mm Hg, with a systolic ejection murmur (Levine III/VI). In the subacute period, no significant
pressure gradient was recorded.
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during sexual intercourse). Inexperienced exercise (dancing,
bowling, gateball; lifting work during house moving) was
also documented in six patients.
As shown in Table 1, 38 patients had a wide spectrum of
onset and aggravation of systemic disease including acute-
phase cerebrovascular accidents (n 5 3), attacks of epilepsy
(n 5 3), exacerbation of bronchial asthma (n 5 3), com-
mencement of dialysis therapy (n 5 4) and acute abdomen
with pain (n 5 7). Moreover, 11 patients exhibited this
syndrome during noncardiac surgery or during a procedure
(intubation, tracheotomy, transbronchial lung biopsy, deliv-
ery, general anesthesia for orthopedic surgery, cholecystec-
tomy, subtotal gastrectomy and colonectomy). The remain-
ing 23 patients had no such specific conditions.
Figure 3. Electrocardiography and left ventriculographic findings of a representative case (Case 2). (Left) 12-lead electrocardiogram showed ST elevation
in leads II, III, aVF and V3 to V6. In the subacute period, the electrocardiogram exhibited a negative T-wave. (Right) Initial left ventriculogram revealed
apical ballooning only in the acute period.
Figure 4. Scintigraphic and positron emission computed tomographic (PET) findings (Case 2). Nuclear cardiographic evaluations showed marked perfusion
(Tc-99m sestamibi [MIBI]) metabolic (I-123 beta-methyl-p-iodophenyl pentadecanoic acid [BMIPP] or I-123 metaiodobenzyl-guanitidine [MIBG])
mismatches mainly at the left ventricular apex. However, in the subacute period, this perfusion metabolic mismatch decreased after the functional recovery
(three-dimensional left ventriculography by Tc-99m MIBI). After five months, PET by N-13 ammonia showed improvement in the coronary flow reserve
(CFR) assessed by dipyridamole administration. EDV 5 end-diastolic volume; EF 5 ejection fraction; ESV 5 end-systolic volume; MBF 5 myocardial
blood flow; SPECT 5 single photon emission computed tomography.
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Clinical backgrounds, symptoms and ECG findings.
The mean age of the selected patients was 67 6 13 years
(range: 10 to 88 years). The number of women (n 5 76) was
about 6.3-fold higher than the number of men (n 5 12).
The percentage of women patients without psychological
problems, exacerbated systemic disorders or surgical proce-
dures was higher than the percentage of those with such
conditions (94% vs. 74%, p 5 0.033). Age distribution in
patients with and without the above mentioned conditions
was similar. The incidences of major coronary risk factors
(hypertension, diabetes and hyperlipidemia) are shown in
Table 2.
Chest pain/discomfort occurred in 45 (90%) of the
patients without any preceding conditions and in 14 (37%)
with exacerbated underlying disorder and procedure (p 5
0.0001). Elevated CK release ranging from 209 to 1,625
IU/l was documented in 26 (52%) patients without and in
23 (61%) patients with possible triggering factors. Only
seven patients exhibited a peak CK value of more than 1,000
IU/l. Elevated troponin T ($0.25 ng/ml) was confirmed in
31 of the 43 patients (72%). In the acute period (6 6 9 h;
range, 1 to 48 h), ST elevation was observed in 79 (90%) of
the patients, including four patients with solitary ST eleva-
tion of limb-lead and 13 patients without right precordial
(V1, V2) ST elevation. ST depression was found in 33
patients, 32 of which had reciprocating ST depression and
one without ST elevation. The remaining eight patients
exhibited T-wave inversion without ST shifts. In the
subacute period (21 6 11 days; range: 14 to 46 days), only
nine (10%) patients exhibited persistent Q-waves on ECG.
No differences in ECG findings were observed between
patients with or without preceding conditions at the onset.
Electrocardiogram findings are summarized in Table 3. The
V3 and V4 leads most frequently showed both ST elevation
and Q-wave formation (Table 3).
Thus, 34 (39%) of the patients fulfilled all of the three
MONICA criteria (15), and 38 (43%) of the patients were
considered as probable cases for AMI. The remaining 16
patients exhibited only ECG changes.
Table 1. Possible Triggering Conditions at the Onset of
Transient Left Ventricular Apical Ballooning
Number of
Patients (%)
Total 88 (100%)
Psychological backgrounds: 18 (20%)
Accidents in family members 2†
Relation’s death or funeral 7
Quarrel or alcohol intake 5†
Vigorous excitation 4
Unusual exercise 6 (7%)
Exacerbated systemic disorders:
Cardiovascular disease: 3 (3%)
Ventricular tachycardia attack 1
Acute chordal rupture 1
Leg pain due to embolism 1
Noncardiovascular disease:
Neurogenic: 6 (7%)
CVA episode 3*
Epileptic attack 3*
Pulmonary: 7 (8%)
Aggravated pneumonia 2
Exacerbated bronchial asthma 3
Embolism 1
Metabolic and endocrine: 2 (2%)
Diabetic nonketotic coma 1
Hypoglycemia episode 1
Renal disease and urinary tract: 5 (6%)
Uremia/dialysis 4
Bladder pain due to obstruction 1
Gastrointestinal: 6 (7%)
Bleeding 2
Gall bladder stone 2*
Acute pancreatitis 2
Noncardiac surgery and procedure: 11 (13%)
Intubation 1
TBLB 1
Delivery 1
Subtotal gastrectomy 1
Cholecystectomy 1
Tracheotomy 1
Orthopedic surgery 4
Colonectomy 1
*†Cases combined or recurrent cases.
CVA 5 cerebrovascular accident; TBLB 5 transbronchial lung biopsy.
Table 2. Patients’ Backgrounds and Characteristics of Left
Ventricular Apical Ballooning (n 5 88)
Age (yr) 67 6 13 (10–88)
Gender (male/female) 12/76
Coronary risk factors (%):
Hypertension 42 (48%)
Diabetes 10 (12%)
Hyperlipidemia 21 (24%)
Familial history 2 (2%)
Onset:
Chest pain/discomfort 59 (67%)
Dyspnea 6 (7%)
Shock 4 (5%)
Electrocardiographic abnormalities 18 (20%)
Enzyme elevation:
Creatine kinase 49 (56%)
Electrocardiogram (%):
ST elevation 79 (90%)
Abnormal Q-wave 24 (27%)
T-wave inversion 39 (44%)
Complications:
Arrhythmias:
Sinus bradycardia 9 (10%)
Atrioventricular block 4 (5%)
Atrial fibrillation 6 (7%)
Ventricular tachycardia fibrillation 8 (9%)
Pulmonary edema 19 (22%)
Cardiogenic shock 13 (15%)
Therapy:
Balloon pumping 7 (8%)
Dopamine/dobutamine 17 (19%)
Outcome:
In-hospital death 1 (1%)
Heart failure at discharge 1 (1%)
Recurrences 2 (2%)
Sudden death 1 (1%)
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Hemodynamics and LV function. The results of LVG in
the acute and in subacute periods are summarized in Table
4. All of the patients exhibited characteristic apical balloon-
ing with mean ejection fraction of 41 6 11% (range: 10% to
62%). However, in the subacute period, the mean ejection
fraction significantly increased to 64 6 10% (ranging from
44% to 88%, p , 0.0001). In the acute period, 12 of 72
(18%) patients had a significant intraventricular pressure
gradient .30 mm Hg. However, no patients exhibited
residual pressure gradient in the subacute period. In an
acetylcholine provocative test, coronary spasm was provoked
in 10 of the 48 (21%) patients.
Complications and clinical outcome. Twenty-four pa-
tients exhibited arrhythmias (atrioventricular block [n 5 4],
sinus bradycardia [n 5 9], paroxysmal atrial fibrillation [n 5
6], ventricular tachycardia [n 5 8], including two with
ventricular fibrillation). Lung congestion and cardiogenic
shock were observed in 19 (22%) and in 13 (15%) of the
patients, respectively. Eighteen patients (20%) required
intravenous dopamine or dobutamine infusion and mechan-
ical supports, including a percutaneous cardiopulmonary
support system used in seven (8%) of the patients in the
acute period. In-hospital death due to multiorgan failure
after pulmonary thromboembolism was documented in only
one patient (1%).
Prescribed medications were calcium channel antagonist
in 47% of the patients, beta- blockers in 18%, angiotensin-
converting enzyme inhibitor in 15%, long-acting nitrate in
47% and diuretics in 19%. Exercise capacities on discharge
were New York Heart Association class I in 85 (97%) of the
patients, but the remaining two patients had a functional
limitation due to advanced age. During a follow-up period
of 13 6 14 months, two of the 72 patients (2.7%) exhibited
recurrence due to other emotional stress, and one patient, in
whom multivessel spasms had been provoked by an intra-
coronary acetylcholine test, died suddenly.
DISCUSSION
Several case studies on transient LV apical ballooning
without stenosis on CAG have been reported in Japan
(1–6), but this is the first report of a multicenter study on a
novel heart syndrome. A total of 88 patients with transient
LV apical ballooning were retrospectively analyzed. The
main results of this study were: 1) acute onset and aggra-
vation of various systemic disorders (cerebrovascular acci-
dents, epileptic attacks, exacerbation of bronchial asthma,
acute abdomen), noncardiac surgery/procedure and emo-
tional/physical problems (sudden accidents, death/funeral of
a family member, inexperienced exercise, quarreling or
excessive alcohol consumption, vigorous excitation) were
found to be possible triggering factors; 2) there were no
differences between clinical characteristics of patients with
and without the above mentioned factors except for gender
likelihood and chest pain/discomfort as an initial symptom;
and 3) transient intraventricular pressure gradient and pro-
vocative coronary vasospasm were observed in some cases.
Pathophysiologic basis of transient LV apical ballooning.
The precise etiologic basis of transient LV apical wall
motion abnormalities could not be determined from the
results of this study. Stunned myocardium is generally
defined as a prolonged postischemic LV dysfunction after
Table 3. Electrocardiographic Findings of Left Ventricular Apical Ballooning
ST Elevation Abnormal Q-Wave T-Wave Inversion
Acute Period Subacute Period Acute Period Subacute Period Acute Period Subacute Period
I 37 (42%) 4 (5%)* 4 (5%) 3 (3%) 11 (15%) 44 (51%)*
II 29 (33%) 1 (1%)* 5 (6%) 1 (1%) 21 (24%) 45 (52%)*
III 22 (25%) 2 (2%)* 7 (8%) 2 (2%) 21 (24%) 41 (47%)*
aVL 24 (27%) 3 (3%)* 4 (5%) 3 (3%) 11 (15%) 30 (35%)*
aVF 26 (30%) 1 (1%)* 3 (3%) 2 (2%) 19 (26%) 40 (49%)*
V1 19 (22%) 1 (1%)* 2 (2%) 0 (0%) 7 (8%) 20 (24%)*
V2 58 (66%) 5 (6%)* 9 (10%) 2 (2%) 13 (15%) 59 (68%)*
V3 68 (77%) 3 (3%)* 16 (18%) 3 (4%)* 23 (26%) 70 (81%)*
V4 67 (76%) 2 (2%)* 12 (14%) 1 (1%)* 26 (30%) 68 (78%)*
V5 55 (63%) 1 (1%)* 6 (7%) 1 (1%) 26 (30%) 68 (78%)*
V6 48 (55%) 1 (1%)* 2 (2%) 0 (0%) 24 (27%) 61 (70%)*
*Statistical significance between electrocardiograms in acute and in subacute period.
Table 4. Catheterization Data
Left ventricular pressure:
End-diastolic 17 6 6
Intraventricular pressure gradient:
Acute 13/72 (18%)
Subacute 0/56 (0%)
Left ventriculography:
Acute: (n 5 76)
EDVI (ml/sqm) 80 6 18
ESVI (ml/sqm) 47 6 14
EF (%) 41 6 11
Subacute: (n 5 56)
EDVI (ml/sqm) 69 6 21*
ESVI (ml/sqm) 26 6 12*
EF (%) 64 6 10*
Provocation of vasospasm (%): 10/48 (21%)
RCA 2
LCA 3
RCA 1 LCA 5
*Statistical significance compared with acute period.
EDVI 5 end-diastolic volume index; EF 5 ejection fraction; ESVI 5 end-systolic
volume index; LCA 5 left coronary artery; RCA 5 right coronary artery.
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brief myocardial ischemia (16). The results of CAG per-
formed immediately after onset showed no definite evidence
of myocardial ischemia originating from epicardial obstruc-
tion in any of the subjects. Therefore, we could not confirm
reversible wall motion abnormality as in apical stunned
myocardium and, instead, named this clinical syndrome
“transient LV apical ballooning.”
Transient wall motion abnormality after multiple vaso-
spastic angina has also been postulated to be a cause of
stunned myocardium (2,7–12,17–19). In our series of cases,
provocative vasospasm was confirmed only in limited cases
(10/48, 21%). Therefore, multiple vasospasm is not thought
to be a main cause. Another possible mechanism is myo-
cardial ischemia due to microvascular spasm. Recently,
Mohri et al. (17) indicated that microvascular spasm is one
type of myocardial ischemia without significant stenosis in
an epicardial artery. Of course, we cannot exclude the
possibility of microvascular spasm and the watershed infarc-
tion, such that occurs in a cerebrovascular accident, because
we could not examine microvascular function.
Several possible triggering conditions that preceded onset
were documented in this study. Exposure to internal (emo-
tional) and external stresses (physical, exacerbated disorder,
procedural and perioperative) was confirmed. As has been
shown in the neurogenic stunned myocardium (7–9) during
acute cerebrovascular accidents and catecholamine cardio-
myopathy during the endocrine crisis of pheochromocytoma
(11,12), enhanced sympathetic activities might be a cause of
similar types of myocardial damages. In our retrospective
registered cases, we did not measure neurohumoral factors
such as the endogenous norepinephrine level, which would
have been helpful in confirming this possibility. Triggering
factors such as emotional exposure, physical stress and
preceding disorders are more important clinical information
as the pathophysiologic basis of this heart syndrome. The
histologic finding in the syndrome by Kawai et al. (6) in this
heart syndrome revealed similar myocardial damage in
catecholamine-induced cardiomyopathy. This novel heart
syndrome might be one of the clinical models of stress-related
sudden death (20–22). However, we found various heteroge-
neous disorders and procedures as possible triggering factors.
All of these conditions might be stressors for patients, but we
cannot rule out the possibility of coincident conditions.
Regional apical ballooning and intraventricular pressure
gradient. It was also not evident why the LV apex is
selectively vulnerable and subsequently forms balloons. Sev-
eral anatomic and physiologic factors might contribute to
LV apical wall motion abnormalities: 1) the fact that the LV
apex does not have a three-layered myocardial structure; 2)
the easy loss of elasticity of LV apex after excessive expan-
sion; 3) the fact that the LV apex is the border zone (locus
minoris) of the perfusion area of major coronary arteries;
and 4) the delay of functional recovery from global dysfunction.
Intraventricular pressure gradients were documented in
several cases in this study. It is unlikely that acute exacer-
bation of midventricular obstruction in hypertrophic cardio-
myopathy is a main cause because no case exhibited ECG or
echocardiographic myocardial hypertrophy. However, a
similar mechanism in apical aneurysm formation in mid-
ventricular obstruction of hypertrophic cardiomyopathy
might contribute to apical ballooning. Compensatory tran-
sient basal hypercontraction may produce midventricular
obstruction and plays an important role in causing apical
ballooning, which might contribute to secondary ischemia
due to increased wall tension.
Clinical implications. This novel clinical syndrome with
chest symptoms and ECG changes mimicking AMI is of
clinical importance even though its etiologic basis is not
clear. First, we had difficulty in differentiating from stenotic
AMI when considering intravenous thrombolysis therapy.
Indeed, chest symptoms and ECG findings are similar to
those in typical cases of AMI. Second, in many patients, this
syndrome occurred in the clinical course of various systemic
diseases in the absence of predisposing angina, making it
difficult to predict the occurrence of attacks. In patients with
a preceding disorder, there might be a diagnostic difficulty
because of the absence of typical chest pain/discomfort and
the higher incidence of pulmonary congestion. Therefore,
careful ECG monitoring will be required. In-hospital prog-
nosis is generally good after appropriate treatment of acute
phase complications such as hypotension, pulmonary con-
gestion and ventricular tachyarrhythmias.
Study limitations. Our study was a retrospective investi-
gation, and there are several limitations. First, the incidence
of this syndrome is not clear, nor is it clear why there was a
large percentage of women with this heart syndrome. The
incidence in women is very high (approximately 6.3-fold
higher than that in men), which is clearly different from the
established male dominance in coronary artery diseases,
including vasospastic angina. However, we could not obtain
specific evidence of female dominance. Third, most previous
case studies of this syndrome have been conducted in Japan
(1–6). Only two case studies outside Japan have been
reported (23,24). Therefore, further cases should be inves-
tigated to determine regional and racial differences. Fourth,
CK was serially examined in these patients, but a more
specific method, such as measurement of troponin T levels,
would be helpful for precise determination of myocardial
injury.
Conclusions. Precise clinical features of a novel heart
syndrome with transient LV ballooning mimicking AMI
occurred and were related to various exacerbated systemic
disorders; noncardiac surgical procedure and various types of
psychotic exposure were shown, but the etiologic basis
should be examined in future prospective studies.
APPENDIX
Cardiovascular Institutes of AP-MI Investigations
Sapporo Medical University (A. Hashimoto, K. Uno, K.
Shimamoto); Sapporo JR Hospital (D. Hotta); Iwate Med-
ical University (T. Suzuki, K. Kikuchi); Sendai Cardiovas-
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cular Center (S. Tanizaki, Y. Hen); Omiya Medical Center,
Jichi Medical University (M. Saito); Yokohama City Uni-
versity Medical Center (T. Saruwatari, I. Kobayashi, M.
Shimizu, T. Saito); Shinsyu University (M. Sasamoto, H.
Ichinose, M. Aizawa, N. Urasawa, K. Iwamura, S. Ikeda);
Osaka City University (J. Yoshikawa); Izumi City Hospital
(Y. Kawase); Wakakusa Daiichi Hospital (K. Misu, T.
Hirooka); National Cardiovascular Center (S. Sakuragi, Y.
Gotoh, H. Nonogi); Osaka City General Hospital (T.
Naruko, A. Ito); Wakayama Medical College (M. Obana,
K. Tomobuchi); Seiyu Memorial Hospital (N. Nakamura);
Tsukazaki Memorial Hospital (H. Iida); Fukuyama Cardio-
vascular Hospital (M. Taniguchi, H. Kohno, S. Haruta);
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